Endogenex Funding: $138M Raised, Series C (2026)

Endogenex funding overview

Endogenex is based in Minneapolis. Endogenex has raised $138M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in March 2026. The round record for Endogenex runs through 2026; nothing later has been disclosed. Investors on record include Arboretum Ventures, Hatteras Venture Partners, Lumira Ventures, Orlando Health Ventures, Intuitive Ventures, Longitude Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

Endogenex at a glance

Total raised: $138M
Latest round: Series C
Latest round date: March 2026
Headquarters: Minneapolis
Notable investors: Arboretum Ventures, Hatteras Venture Partners, Lumira Ventures, Orlando Health Ventures, Intuitive Ventures, Longitude Capital, Mayo Clinic, Santé Ventures

Frequently asked about Endogenex funding

How much has Endogenex raised?: Endogenex has raised $138M in total disclosed funding across the rounds on record.
Who has invested in Endogenex?: Arboretum Ventures, Hatteras Venture Partners, Lumira Ventures, Orlando Health Ventures, Intuitive Ventures, Longitude Capital are named among the investors backing Endogenex.
What was the latest Endogenex funding round?: The most recent disclosed round is a Series C, announced in March 2026.
Where is Endogenex based?: Endogenex is based in Minneapolis.
When did Endogenex last raise?: The last disclosed Endogenex round closed in March 2026 at Series C.

Every Endogenex figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Minneapolis at a similar stage.

Endogenex Funding: $138M Raised, Series C (2026)

Endogenex funding overview

Endogenex at a glance

Frequently asked about Endogenex funding

Companies related to Endogenex (32)

Browse related funding lists (8)